| KHC |
Report |
Adjusted EPS |
IN-LINE |
pred ~$0.530 vs. cons $0.528 |
MEDIUM |
| KHC |
Report |
Net sales |
IN-LINE |
pred ~$6.100B vs. cons $6.120B |
MEDIUM |
| KHC |
Report |
Organic net sales growth |
MISS |
pred ~-4.0% vs. cons -3.57% |
MEDIUM |
| KHC |
Guide |
FY26 organic net sales |
LOWER |
guide ~-2.5% midpoint vs. cons -1.95% |
MEDIUM |
| KHC |
Guide |
FY26 adjusted EPS |
LOWER |
guide ~$2.04 midpoint vs. cons $2.070 |
MEDIUM |
| KHC |
Guide |
Market-share trajectory |
BETTER |
guide ~continued improvement vs. cons UNVERIFIED |
LOW |
| KHC |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| KHC |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — organic miss plus maintained FY guide pressures H2 estimates |
LOW |